ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

OLMA Olema Pharmaceuticals Inc

9.48
-0.35 (-3.56%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Olema Pharmaceuticals Inc OLMA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.35 -3.56% 9.48 13:00:09
始値 安値 高値 終値 前日終値
9.87 9.51 10.09 9.95 9.83
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0905:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
2024/4/0305:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2024/3/1205:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/1205:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/1205:05EDGAR2Form 8-K - Current report
2024/3/1205:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
2024/3/0621:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
2024/3/0507:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2024/3/0104:26EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1506:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1502:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1307:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/1214:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/0621:01GLOBEOlema Oncology to Participate in Upcoming Investor..
2024/2/0607:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0607:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0607:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2024/2/0205:24EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0106:21EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/0104:58EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2921:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0823:07EDGAR2Form 8-K - Current report
2024/1/0822:18EDGAR2Form 8-K - Current report
2024/1/0822:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
2024/1/0607:26EDGAR2Form 8-K - Current report
2024/1/0607:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/0307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:01GLOBEOlema Oncology to Present at 42nd Annual J.P. Morgan..
2023/12/3005:54EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1908:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1307:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0906:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0810:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0810:30EDGAR2Form 3/A - Initial statement of beneficial ownership of..
2023/12/0621:48EDGAR2Form 8-K - Current report
2023/12/0607:15EDGAR2Form 8-K - Current report
2023/12/0602:27GLOBEOlema Oncology Announces Palazestrant Demonstrates..
2023/12/0506:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2023/12/0207:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0100:20EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2907:10GLOBEOlema Oncology to Present New Palazestrant Clinical Data in..
2023/11/2309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2305:25EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2305:04EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock